Clinical Trials Browser

Phase 1/2 × durvalumab × Other solid neoplasm × Clear all

NCT05932199 2025-09-25

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma